Moreover, studies have associated the CXCL4 chemokine ligand to fibrosis in subjects with systemic sclerosis; CXCL4 is a potent promoter of Th2 responses and also has anti-angiogenic properties [32]. This evidence concerns the gene PF4 and systemic sclerosis.